Literature DB >> 1371991

Okadaic acid is a potent angiogenesis inducer.

T Oikawa1, M Suganuma, H Ashino-Fuse, M Shimamura.   

Abstract

Okadaic acid, which is a non-12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoter and an inhibitor of protein phosphatases 1 and 2A, induced angiogenesis in the chorioallantoic membrane of the chick embryo. Its potent angiogenic activity was dose-dependent. The minimum effective dose was 5 fmol/egg and the effective dose for 50% induction was 90 fmol/egg. These results indicated that okadaic acid exhibits angiogenic activity one order of magnitude stronger than that of TPA (reported previously). Moreover, the time-course of angiogenesis induction by okadaic acid was much slower than that by TPA. The difference is consistent with the time-courses of other biochemical and biological activities and also various gene expressions induced by okadaic acid and TPA, indicating that the difference in the time-course is associated with their mechanisms of action. We conclude that okadaic acid induces angiogenesis through a different pathway than does TPA, indicating the existence of a new mechanism of angiogenesis induction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371991      PMCID: PMC5918649          DOI: 10.1111/j.1349-7006.1992.tb02343.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

1.  Inhibition of angiogenesis by vitamin D3 analogues.

Authors:  T Oikawa; K Hirotani; H Ogasawara; T Katayama; O Nakamura; T Iwaguchi; A Hiragun
Journal:  Eur J Pharmacol       Date:  1990-03-20       Impact factor: 4.432

Review 2.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

Authors:  C H Blood; B R Zetter
Journal:  Biochim Biophys Acta       Date:  1990-06-01

3.  Angiogenic factor of a rat mammary tumor cell line (RMT-1) (I). Secretion of two distinct angiogenic factors into serum-free conditioned medium by RMT-1 cells.

Authors:  T Oikawa; K Hirotani; K Yamaoka; T Katayama; T Iwaguchi; H Ito; I Morita; S Murota; T Tominaga; A Hiragun
Journal:  Cancer Lett       Date:  1991-07-26       Impact factor: 8.679

4.  Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.

Authors:  T Oikawa; A Hiragun; Y Yoshida; H Ashino-Fuse; T Tominaga; T Iwaguchi
Journal:  Cancer Lett       Date:  1988-12-01       Impact factor: 8.679

5.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

6.  Apparent "activation" of protein kinases by okadaic acid class tumor promoters.

Authors:  T Sassa; W W Richter; N Uda; M Suganuma; H Suguri; S Yoshizawa; M Hirota; H Fujiki
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

7.  Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells.

Authors:  H Ashino-Fuse; Y Takano; T Oikawa; M Shimamura; T Iwaguchi
Journal:  Int J Cancer       Date:  1989-11-15       Impact factor: 7.396

8.  Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A.

Authors:  C Thévenin; S J Kim; P Rieckmann; H Fujiki; M A Norcross; M B Sporn; A S Fauci; J H Kehrl
Journal:  New Biol       Date:  1990-09

9.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.

Authors:  D Ingber; T Fujita; S Kishimoto; K Sudo; T Kanamaru; H Brem; J Folkman
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

10.  Tumor-promoting phorbol esters induce angiogenesis in vivo.

Authors:  P B Morris; T Hida; P J Blackshear; G K Klintworth; J L Swain
Journal:  Am J Physiol       Date:  1988-02
View more
  1 in total

Review 1.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.